On New Year’s Eve, deCODE genetics, Inc., which filed for chapter 11 protection on November 16, 2009, sought court authority to reject a Change in Control Benefit Plan for the company’s managerial employees. deCODE genetics intends to utilize the chapter 11 case to sell its interests in a subsidiary, Islensk erfdagreining ehf, its intellectual property and certain drug compounds to Saga Investments LLC or a higher bidder

See the rest here:
deCODE genetics Seeks Authority to Reject Executive Benefit Plan

Three weeks ago, as I discussed here , I jumped into the GM